Mechanism of Taohong Siwu Decoction in treating soft tissue injury based on UPLC-Q-TOF-MS,network pharmacology and experimental verification.
10.19540/j.cnki.cjcmm.20210311.403
- Author:
Wei-Jun WANG
1
;
Xue-Yun DUAN
2
;
Wei WANG
2
Author Information
1. the First Clinical College, Hubei University of Chinese Medicine Wuhan 430061, China Hubei Provincial Hospital of Traditional Chinese Medicine Wuhan 430061, China Hubei Province Academy of Traditional Chinese Medicine Wuhan 430074, China.
2. Hubei Provincial Hospital of Traditional Chinese Medicine Wuhan 430061, China Hubei Province Academy of Traditional Chinese Medicine Wuhan 430074, China.
- Publication Type:Journal Article
- Keywords:
Taohong Siwu Decoction;
UPLC-Q-TOF-MS;
inflammation;
network pharmacology;
signaling pathway;
soft tissue injury
- MeSH:
Animals;
Apoptosis;
Drugs, Chinese Herbal;
Rats;
Signal Transduction;
Soft Tissue Injuries
- From:
China Journal of Chinese Materia Medica
2021;46(12):3043-3051
- CountryChina
- Language:Chinese
-
Abstract:
To explore the action mechanism of Taohong Siwu Decoction(THSWD) in the treatment of soft tissue injury(STI) based on UPLC-Q-TOF-MS technique, network pharmacology and experimental verification method. UPLC-Q-TOF-MS technique was used to identify the chemical constituents of THSWD. The active ingredients and predicted target proteins of THSWD were screened out through TCMSP database. Cytoscape software was used to construct the active component-target-pathway network, and STRING database was used for protein interaction analysis. GeneCards and CTD databases were used to screen out relevant targets of STI. GO function and KEGG pathway enrichment analysis were performed through DAVID database. The rat model of STI was constructed, and Western blot was used to verify the effect of THSWD on key targets of relevant pathways. The results showed 40 active ingredients in THSWD, and 141 potential targets and 20 targets of STI. Target enrichment analysis of the active components produced 128 KEGG pathways, which were mainly concentrated in amino acid synthesis and metabolism, disease signaling pathways, apoptosis, inflammation and other relevant pathways. Western blot showed that THSWD intervention could significantly decrease PTGS2, CASP3, NFKB1, p-CASP3 and p-NFKB1, while enhancing the expression of TP53 protein in the STI samples of rats. According to the results of UPLC-Q-TOF-MS, network pharmacology and experimental verification, active ingredients in THSWD may play anti-inflammatory and antioxidant effects in NF-κB signaling pathway and apoptotic pathway, thus playing a role in the treatment of STI.
